• 154,522+ Medical Conferences
  • 285 Specialties
  • 11,293 Organizers
  • 156,433 Speakers
  • 159 Countries
  • 4,785 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Scott L. Nyberg
Scott L. Nyberg

Scott L. Nyberg

    MD, PhD
Professor | Rochester, Minnesota    United States of America
Surgery, Transplant Surgery
Fulminant Hepatic Failure; Artificial Liver Devic Pediatrics,...More
Spoken at 1 event

Biography :

Dr. Nyberg is uniquely trained as a liver transplant surgeon and a biomedical engineer. His laboratory team has extensive expertise in the isolation and cultivation of primary hepatocytes for use in cellular therapies. The lab has designed and tested several bioartificial liver devices, including the current device — the Spheroid Reservoir Bioartificial Liver.

Similarly, the Artificial Liver and Liver Transplantation Laboratory uses genetically engineered pigs with a homozygote deficiency in fumarylacetoacetate hydrolase (FAH). These are the first large animal models of hereditary tyrosinemia type 1 (HT1) in hereditary metabolic liver disease.

Along with tyrosinemia, the phenotype of FAH-deficient pigs includes spontaneous cirrhosis, portal hypertension and possibly hepatocellular carcinoma. Additionally, these animal models may serve as in vivo incubators for production of human hepatocytes. Fetal and young FAH-deficient pigs may facilitate maturation of human induced pluripotent stem cells to hepatocytes.

This work is clinically significant in that it opens the door to new applications of individualized medicine and regenerative medicine. For example, growing a new liver from the patient's own cells may become possible through this research. Other applications include the development of a humanized bioartificial liver support device for treating patients whose liver is failing, either as a bridge to liver transplantation or to aid in spontaneous recovery.

This section has yet to be updated by the speaker.
For speaker's contact information - Contact us


Surgery, Transplant Surgery

Interested Topics

Fulminant hepatic failure; Artificial liver devices, Pediatrics, Pediatrics Adolescent Medicine, Transplant Surgery, Transplantation Surgery, Biomedical Engineering, Surgery, Regenerative medicine, Bioartificial liver, Tyrosinemia, Fulminant hepatic failure, Artificial liver devices, Hereditary metabolic liver disease

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message